[{"Assets_0_Q3_USD":326313000.0,"CommonStockSharesOutstanding_0_Q3_shares":53862617.0,"EarningsPerShareBasic_1_Q3_USD":-0.6,"EarningsPerShareBasic_3_Q3_USD":-1.82,"EarningsPerShareDiluted_1_Q3_USD":-0.6,"EarningsPerShareDiluted_3_Q3_USD":-1.82,"NetIncomeLoss_1_Q3_USD":-32357000.0,"NetIncomeLoss_3_Q3_USD":-87305000.0,"StockholdersEquity_0_Q3_USD":147038000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":53719000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":47879000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":53719000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":47879000.0,"Ticker":"CYTK","CIK":"1061983","name":"CYTOKINETICS INC","OfficialName":"Cytokinetics Incorporated Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3243164482.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171103"}]